Related Experiment Video

Updated: Jul 11, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the

Paulus Kirchhof1, Angelo Auricchio, Jeroen Bax

  • 1Department of Cardiology and Angiology, University Hospital Münster, Albert-Schweitzer-Strasse 33, D-48149 Münster, Germany. kirchhp@uni-muenster.de

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
|September 28, 2007
PubMed

Insights

Atrial fibrillation (AF) trials need comprehensive outcome assessments. This consensus outlines key parameters across seven domains to better evaluate new AF treatments and reduce patient morbidity and mortality.

Area of Science:

  • Cardiology
  • Clinical Trials
  • Medical Research

Background:

  • Atrial fibrillation (AF) is a common arrhythmia with significant morbidity and mortality.
  • Current therapies for AF incompletely address its complex consequences like stroke and heart failure.
  • New AF treatments are under investigation, necessitating robust evaluation methods.

Framework:

  • Expert consensus on required outcome parameters for AF clinical trials.
  • Defines seven essential outcome domains: death, stroke, symptoms/quality of life, rhythm, left ventricular function, cost, and emerging parameters.
  • Provides detailed outcome parameters within each domain for comprehensive assessment.

Implementation:

  • Trials must select a relevant primary outcome.
  • Ensures coverage of all major AF-related morbidity and mortality domains.
  • Standardizes outcome assessment for improved comparability and interpretation of AF trial results.

Implications:

  • Improved evaluation of novel AF therapies.
  • Better understanding of AF's impact on patient outcomes.
  • Guidance for designing future clinical trials in atrial fibrillation.
  • Potential to reduce AF-related burden of disease through optimized treatment strategies.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...